Henry Schein (HSIC) reports earnings tomorrow: what to expect
Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting earnings this Tuesday before market hours. Here’s what you need to know.
Henry Schein beat analysts’ revenue expectations last quarter, reporting revenues of $3.46 billion, up 6.7% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ organic revenue estimates and a beat of analysts’ EPS estimates.
Is Henry Schein a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Henry Schein’s revenue to grow 4.2% year on year, slowing from the 5.2% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Henry Schein has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Henry Schein’s peers in the healthcare equipment and supplies segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Align Technology delivered year-on-year revenue growth of 1.9%, beating analysts’ expectations by 1.1%, and Intuitive Surgical reported revenues up 21.7%, topping estimates by 5.3%. Align Technology’s stock price was unchanged after the resultswhile Intuitive Surgical was down 2.3%.
Read our full analysis of Align Technology’s results here and Intuitive Surgical’s results here.
There has been positive sentiment among investors in the healthcare equipment and supplies segment, with share prices up 3.2% on average over the last month. Henry Schein’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $96.87 (compared to the current share price of $84.87).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.